Chan Henry Lee - Jun 6, 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role
SVP, General Counsel
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
ONC
Transactions as of
Jun 6, 2025
Transactions value $
-$179,280
Form type
4
Date filed
6/10/2025, 04:57 PM
Previous filing
Mar 7, 2025
Next filing
Jun 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lee Chan Henry SVP, General Counsel C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND /s/ Qing Nian, as Attorney-in-Fact 2025-06-10 0001980648

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONC American Depositary Shares Sale -$120K -470 -67.14% $255.78 230 Jun 6, 2025 Direct F1, F2, F3
transaction ONC American Depositary Shares Sale -$59.1K -230 -100% $256.79 0 Jun 6, 2025 Direct F1, F2, F4
holding ONC Ordinary Shares 237K Jun 6, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share represents 13 Ordinary Shares.
F2 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.46 to $256.3911, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.4629 to $256.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.